肾实质体积分析在肾肿瘤患者分肾功能评估中的应用
本研究评估了肾实质体积分析(PVA)在肾肿瘤患者中估计分肾功能(SRF)的效用。对374例接受肾部分切除术(PN)的患者分析显示,基于PVA的SRF估算的术前同侧eGFR与基于核素肾扫描(NRS)的SRF估算值强相关(r=0.94,P<0.001)。此外,PN术后保留的同侧eGFR与保留的肾实质体积强相关,且基于PVA的SRF相关性更强(z=3.15,P=0.002)。对155例根治性肾切除术(RN)患者的平行分析也显示强相关(r=0.87,P<0.001)。
要点
- PVA可用于肾肿瘤患者分肾功能评估,与NRS结果强相关。
- 基于PVA的SRF估算的eGFR与术后肾功能保留相关性更强。
- PVA可通过软件分析术前影像获得,易于融入临床实践。
核心结论
- PVA可用于肾肿瘤患者的分肾功能评估,即使该人群年龄更大、合并症更多且肿瘤可能干扰分析。
- PVA可通过软件分析术前横断面影像获得,因此易于纳入常规临床实践。
研究设计与样本
- 回顾性分析374例肾肿瘤且对侧肾功能正常、接受PN(2010-2018)并有术前/术后NRS和横断面影像的患者。
- 平行分析155例接受RN(2006-2016)并有术前NRS和影像的患者。
主要发现
- PN患者中位年龄62岁,中位肿瘤大小3.4 cm,中位术前同侧肾实质体积181 cm3,中位术前同侧eGFR 36.9 mL/min/1.73 m2。
- 徒手脚本与软件分析的肾实质体积强相关(r=0.98,P<0.001)。
- 基于PVA与NRS的SRF估算的术前同侧eGFR强相关(r=0.94,P<0.001)。
- PN术后保留的同侧eGFR与保留的肾实质体积强相关(所有r>0.60),基于PVA的SRF相关性更强(z=3.15,P=0.002)。
- RN患者中,基于PVA与NRS的SRF估算的对侧肾术前eGFR强相关(r=0.87,P<0.001)。
临床怎么用
- PVA可作为肾肿瘤患者分肾功能评估的替代方法,帮助决定肾部分切除与根治性切除。
- PVA可通过软件分析术前横断面影像获得,便于常规临床应用。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: To evaluate the utility of parenchymal volume analysis (PVA) for estimation of split renal function (SRF) in patients with renal masses. SRF is important for deciding about partial vs radical nephrectomy (PN/RN) and assessing risk for developing severe chronic kidney disease after surgery. For renal donors PVA is routinely used to estimate SRF, but the utility of PVA for the more complex renal mass population remains undefined. PATIENTS AND METHODS: All patients (n = 374) with renal tumours and a normal contralateral kidney managed with PN (2010-2018), with preoperative/postoperative nuclear renal scans (NRS) and cross-sectional imaging were analysed. Parenchymal volumes were measured by free-hand scripting or software analysis. Concordance between ipsilateral estimated glomerular filtration rate (eGFR) values based on SRF from NRS vs PVA were evaluated by Pearson correlation and Bland-Altman plots. Parallel analysis of all 155 patients managed with RN at our centre (2006-2016) with preoperative NRS and imaging was also performed. RESULTS: For PN, the median age and tumour size were 62 years and 3.4 cm, respectively. The median preoperative ipsilateral parenchymal volume and eGFR were 181 cm3 and 36.9 mL/min/1.73 m2 , respectively. Parenchymal volumes estimated by free-hand scripting vs software analyses correlated strongly (r = 0.98, P < 0.001). Preoperative ipsilateral eGFR based on SRF from PVA vs NRS also correlated strongly (r = 0.94, P < 0.001). Ipsilateral eGFR saved after PN correlated strongly with parenchymal volume preserved (all r >0.60); however, the correlation was much stronger when ipsilateral eGFRs were based on SRF from PVA rather than NRS (z-statistic = 3.15, P = 0.002). For RN patients, preoperative eGFR in the contralateral kidney based on SRF from PVA vs NRS also correlated strongly (r = 0.87, P < 0.001). CONCLUSION: PVA has utility for estimation of SRF in patients with renal masses, even though this population is older and more comorbid than renal donors and the tumour can complicate the analysis. PVA can be obtained by software analysis from preoperative cross-sectional imaging and thus readily incorporated into routine clinical practice.
引用
- Ye Y, Tanaka H, Wang Y, et al. Split renal function in patients with renal masses: utility of parenchymal volume analysis vs nuclear renal scans. BJU Int. 2020. PMID: 31971315. doi:10.1111/bju.14997
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。